e-learning
resources
Virtual 2020
Tuesday, 08.09.2020
Treatments and biomarkers for lung allograft function and outcome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant
M. Driskel (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom), M. Al-Aloul (Manchester, United Kingdom)
Source:
Virtual Congress 2020 – Treatments and biomarkers for lung allograft function and outcome
Session:
Treatments and biomarkers for lung allograft function and outcome
Session type:
Oral Presentation
Number:
4728
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Driskel (Manchester, United Kingdom), A. Horsley (Manchester, United Kingdom), M. Al-Aloul (Manchester, United Kingdom). Elevated lung clearance index (LCI) as an early marker of future bronchiolitis obliterans (BOS) post lung transplant. 4728
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS clinical practice guidelines on treatment of sarcoidosis
Related content which might interest you:
Lung clearance index (LCI) as a sensitive marker of post-transplant bronchiolitis obliterans syndrome (BOS)
Source: International Congress 2018 – The value of lung function testing in various pathophysiological conditions
Year: 2018
The Leuven experience of a dichotomy in bronchiolitis obliterans syndrome (BOS) after lung transplantation (LTx)
Source: Annual Congress 2007 - Recent advances in clinical and experimental lung transplantation
Year: 2007
Interferon-γ, IL-17 and MMP-9 in early and late bronchiolitis obliterans (BO) following experimental lung transplantation in rats
Source: Eur Respir J 2007; 30: Suppl. 51, 517s
Year: 2007
Can we predict development of bronchiolitis obliterans syndrome (BOS) according to parameters of oxidative stress in lung transplant recipients?
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
Proteomic analysis of broncho alveolar lavage fluid (BAL-f) in lung transplant recipients (LTR) with bronchiolitis obliterans syndrome (BOS)
Source: Eur Respir J 2006; 28: Suppl. 50, 120s
Year: 2006
Forced oscillometry for early detection of bronchiolitis obliterans (BO) following hematogenous stem cell transplant (HSCT)
Source: International Congress 2018 – The importance of the pulmonary function test in different clinical settings
Year: 2018
Pulmonary distribution of oxygen partial pressure in lung transplant recipients: assessment by oxygen-sensitive
3
He-MRI to indicate bronchiolitis obliterans (BO)
Source: Eur Respir J 2005; 26: Suppl. 49, 176s
Year: 2005
Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
Validation of a bronchiolitis obliterans rat lung transplant model: the role of MMP-9
Source: Eur Respir J 2006; 28: Suppl. 50, 778s
Year: 2006
Plasma CRP levels correlate with markers of airway inflammation after lung transplantation: a role for systemic inflammation in bronchiolitis obliterans syndrome?
Source: Annual Congress 2008 - New insights and treatment options for bronchiolitis obliterans syndrome after lung transplantation
Year: 2008
The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Eur Respir Rev 2008; 17: 90-92
Year: 2008
High resolution CT in children with non transplant obliterative bronchiolitis (OB) and problematic asthma. Correlation with lung function
Source: Annual Congress 2010 - Paediatric respiratory infection, inflammation and immunology
Year: 2010
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Do nitrites (NO
2
) and nitrates (NO
3
) have a role in the development of bronchiolitis obliterans syndrome (BOS) in lung transplant recipients?
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome
Source: ERJ Open Res, 5 (4) 00164-2019; 10.1183/23120541.00164-2019
Year: 2019
Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
Current status of lung transplantation
Source: Eur Respir J 2003; 22: 57S-64S
Year: 2003
Acinar ventilation heterogeneity (Sacin) assessed by nitrogen multiple breath washout is an accurate and sensitive marker of bronchiolitis obliterans (BO)
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Early diagnosis of chronic rejection
Source: Annual Congress 2005 - PG9 - Long-term follow-up of lung transplant recipients
Year: 2005
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept